bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.30.762644

Mapping the sequence determinants of constitutive activity in GPCRs

Howard, M. K.·Whiteman, S.·Rockefeller Grimes, P.·Macdonald, C. B.·Manglik, A.·Coyote-Maestas, W.
View original source ↗Export metadata ↓

Abstract

G protein-coupled receptors (GPCRs) signal not only in response to ligands but also in their absence. This basal, or constitutive, activity has distinct physiological consequences and is the only functional measurement available for orphan receptors. It is also hard to compare receptors because each is reported relative to its own baseline. Here, we measure basal activity on a single scale across the human GPCR family. Pairing a barcoded library of all human GPCRs with a transcriptional cAMP reporter, we scored 901 receptor constructs in one pool experiment. Basal activity forms a continuous distribution, and many of the highest-scoring recipes have prior reports of ligand-independent activity, with orphan being strongly represented. We then exhaustively mutated one of them, GPR161, and measured its effects on protein abundance, surface expression, and cAMP signaling. Of the 528 positions, only 10 specifically alter signaling independent of expression. Constraints on basal signaling are dominated by reepotro biogenesis, which requires multiphenotype scanning to resolve. Together, these datasets place basal activity on a common scale across the GPCR family and provide a template for dissecting it at residue resolution.

Explore related subjects

biochemistryPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Howard, M. K., Whiteman, S., Rockefeller Grimes, P., Macdonald, C. B., Manglik, A., Coyote-Maestas, W.. 2026-11-03. Mapping the sequence determinants of constitutive activity in GPCRs. https://doi.org/10.64898/2026.10.30.762644

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Functional Reconstitution of Human OATP1B1 and OATP1B3 in Proteoliposomes: Effect of Bicarbonate Gradients and Substrate-specific Stimulation on Transport

The hepatic organic anion transporting polypeptides OATP1B1 and OATP1B3 are critical for the clearance of widely prescribed drugs, hepatotoxins, and endogenous metabolites. However, the thermodynamic driving force governing their transport has remained a subject of debate due to the complexity of cellular models. Here, we report a defined, reconstituted proteoliposome system to study the transport kinetics of isolated human OATP1B1 and OATP1B3. Through direct functional assays, real-time counter-ion tracking, and a novel ABCG2-OATP1B1 functional co-reconstitution, we identify an outwardly directed bicarbonate gradient as a thermodynamic driving force for concentrative substrate uptake. In contrast we find no evidence for the proposed role of reduced glutathione efflux as a possible driving force. Targeted mutagenesis experiments revealed that the conserved TM3 residue His115 is needed to couple the bicarbonate gradient to concentrative substrate uptake, mechanistically linking substrate antiport to local pH-sensitive bicarbonate processing. We also investigated the substrate-specific stimulatory effect of the green tea catechin epigallocatechin gallate (EGCG) on OATP1B3 transport, confirming that this effect is intrinsic to OATP1B3, substrate specific, and does not need the involvement of other cellular proteins. Our findings define the energetic basis of OATP1B1 and OATP1B3 hepatic xenobiotic clearance.

biochemistry↗
bioRxiv2026

Direct Bioconjugations of Diverse Payloads using an Extraordinarily Donor-Promiscuous Flavin Transferase

Site-specific protein conjugation is a widely used tool in chemical biology research and is the foundation of many biotechnological and biomedical applications. A key enabling technology are repurposed post-translational protein modifying enzymes, where variants with broad donor and acceptor substrate promiscuity were developed into general-purpose bioconjugation platforms. However, direct enzymatic attachment of bulky or structurally diverse payloads is often limited by low reaction efficiencies and difficulties in preparing suitable donors. Consequently, conjugation typically relies on two-step strategies in which an enzyme first installs a bioorthogonal handle on the target protein, followed by chemical attachment of the payload. These enzyme-first, chemistry-second approaches limit chemistry to bioorthogonal reactions that leave a molecular footprint. Here, we introduce direct ADDing, an enzymatic bioconjugation platform based on our discovery of the exceptional donor promiscuity of the flavin transferase ApbE. We show that ApbE accepts a remarkably broad range of donor substrates provided they carry an adenosine diphosphate (ADP) anchor. The prevalence of ADP-containing compounds in nature provides access to diverse building blocks and an extensive biochemical toolbox for donor generation. Exploiting these resources, we demonstrate multiple strategies for preparing compatible donors and achieve direct, site-specific enzymatic conjugation of diverse small molecules, peptides, proteins, and synthetic polymers.

biochemistry↗
bioRxiv2026

GNG2-MRAS interaction regulates SHOC2-dependent RAF activation and MAPK signaling

Dysregulation of the mitogen-activated protein kinase (MAPK) signaling pathway is a hallmark of many human cancers and RASopathies. The SHOC2-MRAS-PP1C; (SMP) holophosphatase complex is a crucial regulatory node of this pathway. It activates the MAPK pathway by dephosphorylating the inhibitory phosphoserine on RAF kinases and thereby relieving RAF autoinhibition. Although GNG2, the {gamma}-subunit of heterotrimeric G proteins, has recently emerged as a negative modulator of MAPK signaling, its molecular mechanism of action remains incompletely understood. Here, we identify GNG2 and its truncated variants as inhibitors of SMP complex assembly by directly targeting MRAS. Using NanoBiT live-cell bioluminescence, co-immunoprecipitation (Co-IP), biolayer interferometry (BLI), and molecular dynamics simulation studies, we demonstrate that full-length GNG2 (residues 1-71aa) and two helical fragments ({Delta}1, residues 1-29aa and {Delta}2, residues 30-71aa) bind MRAS, disrupt SMP complex formation, and therefore prevent RAF dephosphorylation. Expression of the truncated GNG2 variants significantly reduced phosphorylation of ERK in cells, consistent with inhibition of pathway activation. Furthermore, a short peptide synthesized from the GNG2 {Delta}2 sequence effectively disrupted SMP complex formation in both purified protein systems and live cells and potently attenuated MAPK signaling. Molecular dynamics simulation studies revealed that GNG2 variants engage with the Switch I/II regions of MRAS, sterically interfering with SHOC2-PP1C association. Together, these findings establish GNG2 as a direct regulator of SMP complex assembly and demonstrate that GNG2-derived peptides represent a promising strategy for disrupting SHOC2-MRAS interactions and suppressing MAPK signaling in RAS/RAF-driven pathologies.

biochemistry↗